Drug Trial Radar · NCT00594425
Photodynamic Therapy (PDT) With Methyl Aminolevulinate (MAL) Cream in Moderate to Severe Acne
Last checked: Nov 20, 2026Latest source record: Aug 8, 2013 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
150
Actual
Start
Feb 2007
Primary completion
Jul 2008
Study completion Sep 2008
Sponsor
- Lead sponsor
- PhotocureIndustry
- Sponsor type
- Industry
- First posted
- Jan 15, 2008
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 15 years, up to 40 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This multicenter study will be divided into 2 phases. The first phase will be an open label, dose-escalation phase, while the second will be a blinded, randomized, vehicle-controlled, parallel-group, dose-response phase. The second phase will only start if the first phase succeeds in establishing well tolerated dose(s). Patients with moderate to severe acne vulgaris in the face will be included.The results from part 2 has been presented in the result section.
Conditions
- Acne Vulgaris
Interventions
Methyl aminolevulinate (MAL) PDTDrug
Cream application followed by illumination with red light
Primary outcomes
What the sponsor says the trial is designed to measure.
- Proportion of Success, Defined as Improvement of at Least 2 Grades From Baseline According to the IGA Scale Based on Facial AssessmentTime frame: 12 weeks after last treatment
- Change in Facial Inflammatory (Nodules, Papules, and Pustules) Lesion CountsTime frame: 12 weeks after last treatment
- Change in Facial Inflammatory (Nodules, Papules, and Pustules) Lesion Counts From BaselineTime frame: 12 weeks
Locations
14 sites in 1 country. Site status is shown where the registry gives one.
Therapeutics Clinical Research
San Diego, California
Solano Clinical Research
Vallejo, California
DuPage Medical Group
Naperville, Illinois
Michigan Center for Research Corp
Clinton Twp, Michigan
Academic Dermatology Associates
Albuquerque, New Mexico
Dermatology Associates of Rochester
Rochester, New York
Central Sooner Research
Norman, Oklahoma
Oregon Dermatology and Research Center
Portland, Oregon
Dermatology Treatment & Research
Dallas, Texas
Suzanne Bruce and Associates, PA
Houston, Texas
The Dermatology Clinical Research Center of San Antonio
San Antonio, Texas
Dermatology Research Center, Inc.
Salt Lake City, Utah
The Education & Research Foundation, Inc.
Lynchburg, Virginia
Virginia Clinical Research, Inc.
Norfolk, Virginia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.